Skip to main content
IDF logo
graph image

Treatment experiences and preferences among patients with primary immunodeficiency: National survey of patients (2018)

March 05, 2019

In addition to administering the fifth National Treatment Survey in 2018, IDF also asked participants to complete, where appropriate, the Ig Patient Experience with Treatment (IgPET) Scale, the Treatment Satisfaction Questionnaire for Medication (TSQM-9), SF-12 and SF-10. The National Treatment Experiences and Preferences Survey data provides clinicians, researchers, and, most importantly, patients and their families with the only national estimates of treatment experiences of patients with primary immunodeficiencies. 

Download print material

Requires entering your name and email to download resource and receive IDF emails.

This material is not available to be mailed in hard copy.

Please provide your name and email to view the file.